SciVision Biotech Inc. (TPE:1786)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
67.80
+1.80 (2.73%)
Mar 10, 2026, 9:38 AM CST
-44.20%
Market Cap 4.76B
Revenue (ttm) 886.62M
Net Income (ttm) 162.34M
Shares Out 72.19M
EPS (ttm) 2.18
PE Ratio 30.28
Forward PE n/a
Dividend 3.25 (4.64%)
Ex-Dividend Date Apr 29, 2026
Volume 24,000
Average Volume 341,796
Open 68.00
Previous Close 66.00
Day's Range 67.20 - 68.20
52-Week Range 65.00 - 129.50
Beta 0.51
RSI 31.10
Earnings Date Mar 6, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2025, SciVision Biotech's revenue was 886.62 million, an increase of 0.37% compared to the previous year's 883.31 million. Earnings were 162.34 million, a decrease of -32.99%.

Financial Statements

News

There is no news available yet.